Repligen 2024 J.P. Morgan Healthcare Conference

Repligen CEO Tony Hunt presents at the 42nd J.P. Morgan Healthcare Conference, discussing bioprocessing market recovery and the company's innovation leadership in single-use manufacturing technologies. Highlights include improved order funnel, new product launches, and positioning 2024 as a turning point with anticipated growth recovery in 2025.